Food Allergen Immunotherapy in the Treatment of Patients with IgE-Mediated Food Allergy

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2024 Jan 23

PMID 38256382

Authors

Mirjana Turkalj

Adrijana Miletic Gospic

Ivona Visekruna Dzidic

Ivana Banic

Affiliations

Soon will be listed here.

Abstract

The prevalence of allergic diseases, including food allergy, is increasing, especially in developed countries. Implementation of an elimination diet is not a sufficient therapeutic strategy in patients with food allergy, whose quality of life is significantly impaired. In recent years, new effective therapeutic strategies have been developed, such as the application of oral, sublingual, and epicutaneous immunotherapy. Oral immunotherapy is the most often applied strategy because of its effectiveness and ease of application, with an acceptable safety profile. The effectiveness of oral immunotherapy in patients with egg, cow's milk, and peanut allergy has been proven both in terms of raising of the threshold and the development of tolerance, and in some patients, the development of sustainable unresponsiveness. Although oral immunotherapy is an effective treatment for food allergy, several limitations, including a long duration and a significant rate of reported adverse events, reduces its success. Therefore, new therapeutic options, such as treatment with biologicals, either as combinations with food allergen immunotherapy or as monotherapy with the aim of improving the efficacy and safety of treatment, are being investigated.

References

Geiselhart S, Podzhilkova A, Hoffmann-Sommergruber K . Cow's Milk Processing-Friend or Foe in Food Allergy?. Foods. 2021; 10(3). PMC: 8000412. DOI: 10.3390/foods10030572. View

Bird J, Spergel J, Jones S, Rachid R, Assaad A, Wang J . Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. J Allergy Clin Immunol Pract. 2017; 6(2):476-485.e3. DOI: 10.1016/j.jaip.2017.09.016. View

Palosuo K, Karisola P, Savinko T, Fyhrquist N, Alenius H, Makela M . A Randomized, Open-Label Trial of Hen's Egg Oral Immunotherapy: Efficacy and Humoral Immune Responses in 50 Children. J Allergy Clin Immunol Pract. 2021; 9(5):1892-1901.e1. DOI: 10.1016/j.jaip.2021.01.020. View

Muraro A, de Silva D, Halken S, Worm M, Khaleva E, Arasi S . Managing food allergy: GALEN guideline 2022. World Allergy Organ J. 2022; 15(9):100687. PMC: 9467869. DOI: 10.1016/j.waojou.2022.100687. View

Leung D, Sampson H, Yunginger J, Burks Jr A, Schneider L, Wortel C . Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med. 2003; 348(11):986-93. DOI: 10.1056/NEJMoa022613. View

Fleischer D, Greenhawt M, Sussman G, Begin P, Nowak-Wegrzyn A, Petroni D . Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial. JAMA. 2019; 321(10):946-955. PMC: 6439674. DOI: 10.1001/jama.2019.1113. View

Spergel J, Elci O, Muir A, Liacouras C, Wilkins B, Burke D . Efficacy of Epicutaneous Immunotherapy in Children With Milk-Induced Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2019; 18(2):328-336.e7. DOI: 10.1016/j.cgh.2019.05.014. View

Santos A, James L, Kwok M, McKendry R, Anagnostou K, Clark A . Peanut oral immunotherapy induces blocking antibodies but does not change the functional characteristics of peanut-specific IgE. J Allergy Clin Immunol. 2019; 145(1):440-443.e5. DOI: 10.1016/j.jaci.2019.09.005. View

Jones S, Burks A, Dupont C . State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous. J Allergy Clin Immunol. 2014; 133(2):318-23. DOI: 10.1016/j.jaci.2013.12.1040. View

10.

Dang T, Peters R, Allen K . Debates in allergy medicine: baked egg and milk do not accelerate tolerance to egg and milk. World Allergy Organ J. 2016; 9:2. PMC: 4727327. DOI: 10.1186/s40413-015-0090-z. View

11.

Hise K, Rabin R . Oral Immunotherapy for Food Allergy-a US Regulatory Perspective. Curr Allergy Asthma Rep. 2020; 20(12):77. DOI: 10.1007/s11882-020-00973-x. View

12.

Kim E, Keet C, Virkud Y, Chin S, Ye P, Penumarti A . Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children. J Allergy Clin Immunol. 2023; 151(6):1558-1565.e6. PMC: 10257751. DOI: 10.1016/j.jaci.2023.01.036. View

13.

Burks A, Wood R, Jones S, Sicherer S, Fleischer D, Scurlock A . Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol. 2015; 135(5):1240-8.e1-3. PMC: 4527157. DOI: 10.1016/j.jaci.2014.12.1917. View

14.

Patil S, Steinbrecher J, Calatroni A, Smith N, Ma A, Ruiter B . Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy. J Allergy Clin Immunol. 2019; 144(5):1310-1319.e4. PMC: 6905043. DOI: 10.1016/j.jaci.2019.07.028. View

15.

Varshney P, Jones S, Scurlock A, Perry T, Kemper A, Steele P . A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol. 2011; 127(3):654-60. PMC: 3060783. DOI: 10.1016/j.jaci.2010.12.1111. View

16.

Ibanez-Sandin M, Escudero C, Candon Morillo R, Lasa E, Marchan-Martin E, Sanchez-Garcia S . Oral immunotherapy in severe cow's milk allergic patients treated with omalizumab: Real life survey from a Spanish registry. Pediatr Allergy Immunol. 2021; 32(6):1287-1295. DOI: 10.1111/pai.13517. View

17.

Tsai M, Mukai K, Chinthrajah R, Nadeau K, Galli S . Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE. J Allergy Clin Immunol. 2019; 145(3):885-896.e6. PMC: 6957313. DOI: 10.1016/j.jaci.2019.10.038. View

18.

MacGinnitie A, Rachid R, Gragg H, Little S, Lakin P, Cianferoni A . Omalizumab facilitates rapid oral desensitization for peanut allergy. J Allergy Clin Immunol. 2016; 139(3):873-881.e8. PMC: 5369605. DOI: 10.1016/j.jaci.2016.08.010. View

19.

Keet C, Frischmeyer-Guerrerio P, Thyagarajan A, Schroeder J, Hamilton R, Boden S . The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol. 2011; 129(2):448-55, 455.e1-5. PMC: 3437605. DOI: 10.1016/j.jaci.2011.10.023. View

20.

van Boven F, Arends N, Sprikkelman A, Emons J, Hendriks A, van Splunter M . Tolerance Induction in Cow's Milk Allergic Children by Heated Cow's Milk Protein: The iAGE Follow-Up Study. Nutrients. 2023; 15(5). PMC: 10005260. DOI: 10.3390/nu15051181. View